Insulin aspart, recombinant Subcutaneous and Sodium ferric gluconate complex
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Sodium ferric gluconate complex and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: sodium ferric gluconate complex
Brand name: Ferrlecit, Nulecit
Synonyms: Ferric Gluconate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Sodium ferric gluconate complex Intravenous
- Insulin aspart, recombinant Subcutaneous-Sodium Glycerophosphate Pentahydrate
- Insulin aspart, recombinant Subcutaneous-Sodium hyaluronate injection
- Insulin aspart, recombinant Subcutaneous-Sodium Iodide
- Insulin aspart, recombinant Subcutaneous-Sodium Iodide I
- Insulin aspart, recombinant Subcutaneous-Sodium Iodide I 123
- Sodium ferric gluconate complex-Insulin degludec
- Sodium ferric gluconate complex-Insulin Degludec (U-100) Prefilled Pens
- Sodium ferric gluconate complex-Insulin Degludec (U-100) Vials
- Sodium ferric gluconate complex-Insulin Degludec (U-200) Prefilled Pens
- Sodium ferric gluconate complex-Insulin degludec and liraglutide
- Sodium ferric gluconate complex-Insulin degludec and liraglutide Subcutaneous